Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
Expert Review of Vaccines
|
March 12, 2026
Vaccine effectiveness against medically-attended, laboratory-confirmed influenza in the I-MOVE primary care network in Europe, VEBIS project, 2024/25
Héloïse Lucaccioni, Francisco Pozo, Gloria Pérez-Gimeno, et al.
Influenza and Other Respiratory Viruses
|
February 25, 2024
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network
Angela M C Rose, Francisco Pozo, Iván Martínez-Baz, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
June 13, 2025
Influenza vaccine effectiveness in Europe and the birth cohort effect against influenza A(H1N1)pdm09: VEBIS primary care multicentre study, 2023/24
Esther Kissling, Marine Maurel, Francisco Pozo, et al.
Influenza and Other Respiratory Viruses
|
November 25, 2025
COVID-19 Vaccine Effectiveness Against Hospitalization in Older Adults, VEBIS Hospital Network, Europe, September 2024-May 2025
Madelyn Rojas-Castro, Nuno Verdasca, Susana Monge, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
November 1, 2024
Effectiveness of the autumn 2023 COVID-19 vaccine dose in hospital-based healthcare workers: results of the VEBIS healthcare worker vaccine effectiveness cohort study, seven European countries, season 2023/24
Camelia Savulescu, Albert Prats-Uribe, Kim Brolin, et al.
JAMA Network Open
|
July 1, 2024
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans
Charlotte Laniece Delaunay, Clara Mazagatos, Iván Martínez-Baz, et al.
Influenza and Other Respiratory Viruses
|
January 11, 2024
Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study
Marine Maurel, Francisco Pozo, Gloria Pérez-Gimeno, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
March 29, 2024
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022
Charlotte Lanièce Delaunay, Iván Martínez-Baz, Noémie Sève, et al.
BMC Medicine
|
November 4, 2025
Vaccine effectiveness against influenza A in older adults and the effect of chronic conditions: results from the I-MOVE and VEBIS multicentre European hospital case-control studies, 2015/16-2023/24
Angela Mary Catherine Rose, Nathalie Nicolay, Clara Mazagatos, et al.
BMC Medicine
|
December 30, 2025
Hybrid, infection- and vaccination-induced protection against laboratory- confirmed SARS-CoV-2 infection in a European multi-centre prospective cohort of healthcare workers, 2021-2024
Madelyn Rojas-Castro, Ranya Mulchandani, Kim Brolin, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
Expert Review of Vaccines
|
March 12, 2026
Vaccine effectiveness against medically-attended, laboratory-confirmed influenza in the I-MOVE primary care network in Europe, VEBIS project, 2024/25
Héloïse Lucaccioni, Francisco Pozo, Gloria Pérez-Gimeno, et al.
Influenza and Other Respiratory Viruses
|
February 25, 2024
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network
Angela M C Rose, Francisco Pozo, Iván Martínez-Baz, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
June 13, 2025
Influenza vaccine effectiveness in Europe and the birth cohort effect against influenza A(H1N1)pdm09: VEBIS primary care multicentre study, 2023/24
Esther Kissling, Marine Maurel, Francisco Pozo, et al.
Influenza and Other Respiratory Viruses
|
November 25, 2025
COVID-19 Vaccine Effectiveness Against Hospitalization in Older Adults, VEBIS Hospital Network, Europe, September 2024-May 2025
Madelyn Rojas-Castro, Nuno Verdasca, Susana Monge, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
November 1, 2024
Effectiveness of the autumn 2023 COVID-19 vaccine dose in hospital-based healthcare workers: results of the VEBIS healthcare worker vaccine effectiveness cohort study, seven European countries, season 2023/24
Camelia Savulescu, Albert Prats-Uribe, Kim Brolin, et al.
JAMA Network Open
|
July 1, 2024
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans
Charlotte Laniece Delaunay, Clara Mazagatos, Iván Martínez-Baz, et al.
Influenza and Other Respiratory Viruses
|
January 11, 2024
Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study
Marine Maurel, Francisco Pozo, Gloria Pérez-Gimeno, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
March 29, 2024
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022
Charlotte Lanièce Delaunay, Iván Martínez-Baz, Noémie Sève, et al.
BMC Medicine
|
November 4, 2025
Vaccine effectiveness against influenza A in older adults and the effect of chronic conditions: results from the I-MOVE and VEBIS multicentre European hospital case-control studies, 2015/16-2023/24
Angela Mary Catherine Rose, Nathalie Nicolay, Clara Mazagatos, et al.
BMC Medicine
|
December 30, 2025
Hybrid, infection- and vaccination-induced protection against laboratory- confirmed SARS-CoV-2 infection in a European multi-centre prospective cohort of healthcare workers, 2021-2024
Madelyn Rojas-Castro, Ranya Mulchandani, Kim Brolin, et al.
Page
of 5